Xanax is produced by Viatris, Inc. [1] Viatris was formed in November 2020 through the combination of Mylan and Upjohn, a Pfizer division [1][2].
What is the history of Xanax production?
Prior to its formation, Xanax was a product of the Upjohn Company [2]. Upjohn was acquired by Pharmacia in 1995, and Pharmacia was later acquired by Pfizer in 2003 [2]. The Upjohn business, which included Xanax, then became part of Pfizer [2]. In 2020, Pfizer spun off its Upjohn division and combined it with Mylan to create Viatris [1][2].
When does the patent for Xanax expire?
The original patents for alprazolam, the active ingredient in Xanax, have long expired [3]. This means that generic versions of alprazolam have been available for many years [3]. However, Viatris may hold other patents related to specific formulations or manufacturing processes for Xanax [4]. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com [4].
Are there generic versions of Xanax available?
Yes, due to the expiry of the original patents, numerous generic versions of alprazolam are available on the market [3]. These generics are produced by various pharmaceutical companies and are typically prescribed as alternatives to brand-name Xanax [3].